Don't take this lying down: an urgent wakeup call: the weight of diet and lifestyle in the young-onset colorectal cancer surge

IF 1.6 4区 医学 Q3 SURGERY ANZ Journal of Surgery Pub Date : 2025-02-01 DOI:10.1111/ans.19416
Maria Kristina Vanguardia MBBS, FRACS, Chen Lew BMedSci, MD, Thang Chien Nguyen MBBS, FRACS, William Teoh MBBS, FRACS, Vignesh Narasimhan PhD, FRACS
{"title":"Don't take this lying down: an urgent wakeup call: the weight of diet and lifestyle in the young-onset colorectal cancer surge","authors":"Maria Kristina Vanguardia MBBS, FRACS,&nbsp;Chen Lew BMedSci, MD,&nbsp;Thang Chien Nguyen MBBS, FRACS,&nbsp;William Teoh MBBS, FRACS,&nbsp;Vignesh Narasimhan PhD, FRACS","doi":"10.1111/ans.19416","DOIUrl":null,"url":null,"abstract":"<p>The overall decline in colorectal cancer (CRC) incidence in developed nations is overshadowed by a worrying anomaly: a rise in young-onset colorectal cancer (YO-CRC), broadly accepted as CRC diagnosed in patients under the age of 50. Currently, about 10–12% of all new diagnoses of CRC are in patients under 50.<span><sup>1, 2</sup></span> Projections suggest that by 2030, YO-CRC would account for a quarter of all rectal cancers.<span><sup>3</sup></span> Additionally, YO-CRC is projected to become the leading cause of cancer related mortality in those aged 20–49 by 2030.<span><sup>4</sup></span> Locally, Australia and New Zealand have some of highest age standardized incidence rates of CRC in the world.<span><sup>5</sup></span></p><p>YO-CRCs are more often left sided, and present at more advanced stages of disease, with a delayed time to diagnosis. They are also more likely to present with synchronous metastases.<span><sup>3</sup></span> Studies show that about two thirds of YO-CRCs have seen at least two physicians before being correctly diagnosed, with over 40% waiting at least 6 months after experiencing symptoms before seeking medical attention.<span><sup>6</sup></span> Some studies suggest YO-CRCs demonstrate more aggressive histopathological subtypes, such as mucinous adenocarcinoma and signet ring pathology.<span><sup>3, 5, 7</sup></span></p><p>Genetics do provide some clues, but its exact impact is unclear. YO-CRC patients are almost twice as likely to have pathogenic variants (17%–25%), with about half due to mutations in lynch syndrome genes. The significance of the other pathogenic variants and its relation to CRC is unclear.<span><sup>8</sup></span> The role of low-moderate penetrance variants, and their gene-environmental interactions, particularly early in life is an area of ongoing research. A positive family history of CRC in at least one first degree relative is reported in up to 30% of YO-CRCs.<span><sup>1</sup></span></p><p>In keeping with the concept of the birth cohort effect, issues such as obesity, sedentary lifestyle and dietary changes have seen major shifts in recent decades. This is in line with a similar increase in YO-CRC rates across successive birth cohorts. Obesity and the metabolic syndrome are associated with a significantly increased relative risk for CRC. The Nurses Health Study II reported a significantly higher relative risk for CRC based on BMI, with an incrementally higher risk in obese compared to overweight patients. Childhood obesity sadly has seen a 200% rise since the 1960s.<span><sup>9</sup></span> Similarly, sedentary jobs and lifestyle, which have increased over 80% since the 1950s have been shown to render a significantly increased relative risk for YO-CRC, particularly rectal cancer.<span><sup>10</sup></span> The metabolic syndrome, with its associated conditions (hypertension, hyperlipidaemia, hyperglycaemia) are strongly associated with an increased risk of YO-CRC, with incrementally increased odds with each additional component of the metabolic syndrome.<span><sup>11</sup></span> Consumption of sugary beverages have similarly been associated with an increased relative risk for YO-CRC, with an increasing risk based on consumption.<span><sup>12</sup></span></p><p>One of the pivotal advances in recent years has been the recognition that the gut microbiome plays a central role in the development of CRC. Bacteria such a fusobacterium species, bacteroides fragiles, pks+ <i>E. Coli</i>, salmonella enterica are strongly associated with CRC carcinogenesis through a variety of mechanisms.<span><sup>13, 14</sup></span> Overuse of antibiotics in recent years is a growing health concern. Additionally, epidemiological studies support an association between antibiotic exposure and development of CRC. The general theory is that antibiotic usage early in life perturbs the gut microbiome, with possible loss of protective microbiota early in life. This alteration in the microbiome may contribute to pro-inflammatory and pro-carcinogenic consequences, which may predispose individuals to YO-CRC.<span><sup>5</sup></span></p><p>The concept of the exposome has also come to the fore in recent years. The notion of the exposome suggests that environmental factors that have seen a similar temporal trend to YO-CRC over time and potentially alter the gut microbiome contribute to the development of YO-CRC.<span><sup>14</sup></span> It is likely a complex interplay wherein exposure to exposomal elements such as the westernized diet, red and processed meat in conjunction with other events early in life like exposure to antibiotics, synthetic dyes, microplastics alter the gut microbiome in childhood. The altered microbiome early in life along with ongoing exposure to environmental factors such as obesity through childhood and adolescence causes alterations in gut immunity and inflammation and likely confer an increased risk of developing YO-CRC to individuals with underlying genetic susceptibility.<span><sup>9, 10</sup></span></p><p>The causative factors contributing to YO-CRC are no doubt complex. The growing tide in YO-CRC has led to several countries, including Australia to lower the screening age to 45. A more holistic examination of environmental influences from early in life is needed to help understand and address risk reduction in YO-CRC. There remains ongoing research into areas such as understanding gene-environmental interactions, susceptibility of the gut to carcinogenic exposures at various ages, role of microbiome and inflammation, with ongoing prospective projects such as GUTS, ORIGINS project in progress. The coming years will hopefully offer more insights into better understanding the key drivers and implementation of preventative strategies in dealing with YO-CRC.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":"95 5","pages":"857-858"},"PeriodicalIF":1.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ans.19416","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ANZ Journal of Surgery","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ans.19416","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

The overall decline in colorectal cancer (CRC) incidence in developed nations is overshadowed by a worrying anomaly: a rise in young-onset colorectal cancer (YO-CRC), broadly accepted as CRC diagnosed in patients under the age of 50. Currently, about 10–12% of all new diagnoses of CRC are in patients under 50.1, 2 Projections suggest that by 2030, YO-CRC would account for a quarter of all rectal cancers.3 Additionally, YO-CRC is projected to become the leading cause of cancer related mortality in those aged 20–49 by 2030.4 Locally, Australia and New Zealand have some of highest age standardized incidence rates of CRC in the world.5

YO-CRCs are more often left sided, and present at more advanced stages of disease, with a delayed time to diagnosis. They are also more likely to present with synchronous metastases.3 Studies show that about two thirds of YO-CRCs have seen at least two physicians before being correctly diagnosed, with over 40% waiting at least 6 months after experiencing symptoms before seeking medical attention.6 Some studies suggest YO-CRCs demonstrate more aggressive histopathological subtypes, such as mucinous adenocarcinoma and signet ring pathology.3, 5, 7

Genetics do provide some clues, but its exact impact is unclear. YO-CRC patients are almost twice as likely to have pathogenic variants (17%–25%), with about half due to mutations in lynch syndrome genes. The significance of the other pathogenic variants and its relation to CRC is unclear.8 The role of low-moderate penetrance variants, and their gene-environmental interactions, particularly early in life is an area of ongoing research. A positive family history of CRC in at least one first degree relative is reported in up to 30% of YO-CRCs.1

In keeping with the concept of the birth cohort effect, issues such as obesity, sedentary lifestyle and dietary changes have seen major shifts in recent decades. This is in line with a similar increase in YO-CRC rates across successive birth cohorts. Obesity and the metabolic syndrome are associated with a significantly increased relative risk for CRC. The Nurses Health Study II reported a significantly higher relative risk for CRC based on BMI, with an incrementally higher risk in obese compared to overweight patients. Childhood obesity sadly has seen a 200% rise since the 1960s.9 Similarly, sedentary jobs and lifestyle, which have increased over 80% since the 1950s have been shown to render a significantly increased relative risk for YO-CRC, particularly rectal cancer.10 The metabolic syndrome, with its associated conditions (hypertension, hyperlipidaemia, hyperglycaemia) are strongly associated with an increased risk of YO-CRC, with incrementally increased odds with each additional component of the metabolic syndrome.11 Consumption of sugary beverages have similarly been associated with an increased relative risk for YO-CRC, with an increasing risk based on consumption.12

One of the pivotal advances in recent years has been the recognition that the gut microbiome plays a central role in the development of CRC. Bacteria such a fusobacterium species, bacteroides fragiles, pks+ E. Coli, salmonella enterica are strongly associated with CRC carcinogenesis through a variety of mechanisms.13, 14 Overuse of antibiotics in recent years is a growing health concern. Additionally, epidemiological studies support an association between antibiotic exposure and development of CRC. The general theory is that antibiotic usage early in life perturbs the gut microbiome, with possible loss of protective microbiota early in life. This alteration in the microbiome may contribute to pro-inflammatory and pro-carcinogenic consequences, which may predispose individuals to YO-CRC.5

The concept of the exposome has also come to the fore in recent years. The notion of the exposome suggests that environmental factors that have seen a similar temporal trend to YO-CRC over time and potentially alter the gut microbiome contribute to the development of YO-CRC.14 It is likely a complex interplay wherein exposure to exposomal elements such as the westernized diet, red and processed meat in conjunction with other events early in life like exposure to antibiotics, synthetic dyes, microplastics alter the gut microbiome in childhood. The altered microbiome early in life along with ongoing exposure to environmental factors such as obesity through childhood and adolescence causes alterations in gut immunity and inflammation and likely confer an increased risk of developing YO-CRC to individuals with underlying genetic susceptibility.9, 10

The causative factors contributing to YO-CRC are no doubt complex. The growing tide in YO-CRC has led to several countries, including Australia to lower the screening age to 45. A more holistic examination of environmental influences from early in life is needed to help understand and address risk reduction in YO-CRC. There remains ongoing research into areas such as understanding gene-environmental interactions, susceptibility of the gut to carcinogenic exposures at various ages, role of microbiome and inflammation, with ongoing prospective projects such as GUTS, ORIGINS project in progress. The coming years will hopefully offer more insights into better understanding the key drivers and implementation of preventative strategies in dealing with YO-CRC.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
这是一个紧急的警钟:饮食和生活方式的重量在年轻发病的结直肠癌中激增。
在发达国家,结直肠癌(CRC)发病率的总体下降被一个令人担忧的异常现象所掩盖:年轻发病的结直肠癌(YO-CRC)发病率的上升,人们普遍认为50岁以下的患者被诊断为结直肠癌。目前,在所有新诊断的结直肠癌中,约有10-12%的患者年龄在50.1岁以下,2预测表明,到2030年,YO-CRC将占所有直肠癌的四分之一此外,到2030年,YO-CRC预计将成为20-49岁人群癌症相关死亡的主要原因。4澳大利亚和新西兰是世界上CRC年龄标准化发病率最高的国家之一。5yo - crc更常出现在左侧,出现在疾病的晚期,诊断时间较晚。他们也更有可能出现同步转移研究表明,大约三分之二的YO-CRCs在得到正确诊断之前至少看过两名医生,超过40%的人在出现症状后至少等待6个月才寻求医疗救助一些研究表明yo - crc表现出更具侵袭性的组织病理学亚型,如粘液腺癌和印戒病理。遗传学确实提供了一些线索,但其确切影响尚不清楚。YO-CRC患者有致病变异的可能性几乎是其两倍(17%-25%),其中约一半是由于lynch综合征基因突变。其他致病变异的意义及其与结直肠癌的关系尚不清楚中低外显率变异的作用及其基因与环境的相互作用,特别是在生命早期,是一个正在进行的研究领域。据报道,高达30%的yo -CRC患者至少有一个一级亲属有CRC家族史。与出生队列效应的概念一致,肥胖、久坐不动的生活方式和饮食变化等问题在最近几十年发生了重大变化。这与连续出生队列中YO-CRC率的类似增加是一致的。肥胖和代谢综合征与结直肠癌的相对风险显著增加相关。护士健康研究II报告了基于BMI的CRC的相对风险显着增加,与超重患者相比,肥胖患者的风险增加。可悲的是,自20世纪60年代以来,儿童肥胖率上升了200%同样,自20世纪50年代以来,久坐不动的工作和生活方式增加了80%以上,这已被证明会显著增加YO-CRC的相对风险,尤其是直肠癌代谢综合征及其相关疾病(高血压、高脂血症、高血糖)与YO-CRC风险增加密切相关,且代谢综合征的每一附加成分都增加了YO-CRC风险的增加同样,含糖饮料的消费与YO-CRC的相对风险增加有关,并且基于消费的风险增加。近年来的关键进展之一是认识到肠道微生物群在结直肠癌的发展中起着核心作用。梭杆菌、脆弱类杆菌、pks+大肠杆菌、肠沙门氏菌等细菌通过多种机制与结直肠癌的癌变密切相关。13,14近年来,抗生素的过度使用是一个日益严重的健康问题。此外,流行病学研究支持抗生素暴露与结直肠癌发展之间的关联。一般的理论是,在生命早期使用抗生素会扰乱肠道微生物群,可能会在生命早期失去保护微生物群。微生物组的这种改变可能导致促炎和亲致癌的后果,这可能使个体易患YO-CRC。近年来,暴露的概念也开始出现。暴露的概念表明,随着时间的推移,环境因素与YO-CRC具有相似的时间趋势,并可能改变肠道微生物群,从而促进YO-CRC的发展这可能是一个复杂的相互作用,暴露于暴露体因素,如西化饮食、红肉和加工肉,再加上生命早期的其他事件,如接触抗生素、合成染料、微塑料,会改变儿童时期的肠道微生物群。生命早期微生物组的改变,以及童年和青春期肥胖等环境因素的持续暴露,会导致肠道免疫和炎症的改变,并可能使具有潜在遗传易感性的个体患YO-CRC的风险增加。导致YO-CRC的因素无疑是复杂的。YO-CRC的增长趋势导致包括澳大利亚在内的一些国家将筛查年龄降至45岁。需要对生命早期的环境影响进行更全面的检查,以帮助了解和解决减少YO-CRC风险的问题。 在了解基因-环境相互作用、不同年龄肠道对致癌物暴露的易感性、微生物组和炎症的作用等领域仍有正在进行的研究,正在进行的前瞻性项目如GUTS、ORIGINS项目正在进行中。未来几年将有望提供更多的见解,以便更好地理解处理YO-CRC的主要驱动因素和预防性战略的实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ANZ Journal of Surgery
ANZ Journal of Surgery 医学-外科
CiteScore
2.50
自引率
11.80%
发文量
720
审稿时长
2 months
期刊介绍: ANZ Journal of Surgery is published by Wiley on behalf of the Royal Australasian College of Surgeons to provide a medium for the publication of peer-reviewed original contributions related to clinical practice and/or research in all fields of surgery and related disciplines. It also provides a programme of continuing education for surgeons. All articles are peer-reviewed by at least two researchers expert in the field of the submitted paper.
期刊最新文献
Methods and Timing of the Assessment of Post-Operative Pain in Minimally Invasive Hernia Surgery: A Scoping Review Comparing Robotic With Laparoscopic Repair. Expanding the Practice of Day-Case Inguinal, Femoral and Umbilical Hernia Repair: A Review of Patient and Procedural Factors Facilitating and Precluding Same-Day Discharge. Predictors of Success With Sacral Nerve Stimulation for Faecal Incontinence-Results From a Single Centre Over 15 Years. Two Decades of Multimodal Management of Colorectal Liver Metastases With Long-Term Outcomes. Two Decades of Evolution in Abdominal Trauma Surgery: Trends, Outcomes, and Implications From an Australian Level 1 Trauma Centre.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1